If drugmakers have their way, the federal government likely ends up spending $100 billion of taxpayer funds to bail out rural hospitals.

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

The 340B program was established by Congress in 1992 to provide steep discounts to hospitals that serve a large proportion of ...

For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving ...

The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing ( discussing the 340B program and its growth and impacts on patients.

A recent report from the Congressional Budget Office found no evidence that savings from the 340B program are passed on to ...

Inaccurate information, pushbacks and undue limitations imposed by pharmaceutical manufacturers pose a threat to the 340B ...